Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal tubular reabsorption refers to the process by which the kidneys, specifically the proximal tubules, reclaim substances, including radiolabeled peptides, from the filtrate back into the bloodstream after glomerular filtration. This physiological mechanism, primarily driven by megalin/cubilin-mediated endocytosis in the proximal convoluted tubule, is crucial for maintaining homeostasis but also presents challenges in nuclear medicine and targeted radionuclide therapy due to potential nephrotoxicity from peptide retention. Strategies to mitigate renal uptake include structural modification of peptides and co-infusion with competitive inhibitors.
Receptor-mediated endocytosis via megalin/cubilin complexes
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal Tubular Reabsorption (N/A).